JSZY(SH:600770)2020-10-23 16:00Financial Performance - Net profit attributable to shareholders was CNY 220,625,682.20, an increase of 1,266.43% year-on-year[6]. - Operating revenue for the first nine months was CNY 328,881,284.58, down 8.76% from the same period last year[6]. - Basic earnings per share rose to CNY 0.17, a 1,600% increase compared to CNY 0.01 in the previous year[6]. - The company's net profit for Q3 2020 was CNY 35,083,647.85, a significant increase compared to a net loss of CNY 5,470,558.86 in the same period last year[25]. - Total revenue for Q3 2020 reached CNY 1,823.01 million, while the revenue for the first three quarters of 2020 was CNY 3,867.51 million, showing a decline from CNY 4,000.00 million in the previous year[28]. - The operating profit for Q3 2020 was CNY 41,883,145.64, compared to CNY 7,902,878.06 in Q3 2019, indicating a strong recovery in operational performance[25]. - The company reported a total comprehensive income of CNY -3,279,027.51 for Q3 2020, a decrease from CNY 28,405,476.70 in the same quarter last year[26]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 6,117,318,738.72, a decrease of 0.42% compared to the end of the previous year[6]. - Total liabilities decreased to ¥970,852,337.80 from ¥1,264,728,284.78, reflecting a reduction in short-term borrowings and other liabilities[17]. - The total assets as of Q3 2020 amounted to ¥3,247,242,020.04, compared to ¥3,573,062,353.43 in the previous period[21]. - Total liabilities decreased to ¥984,787,384.07 in Q3 2020 from ¥1,289,199,951.78 in the previous period, indicating a reduction of approximately 23.6%[21]. - The company's total equity was reported at ¥2,262,454,635.97, down from ¥2,283,862,401.65 in the previous period[21]. - Total current liabilities were ¥1,078,291,143.01 as of the third quarter of 2020[38]. - Total liabilities amounted to approximately $1.29 billion, with current liabilities at approximately $1.28 billion[43]. Cash Flow - Net cash flow from operating activities for the first nine months was CNY 37,078,265.98, up 13.39% year-on-year[6]. - The net cash flow from operating activities for the first three quarters of 2020 was CNY 359,355,473.10, compared to a negative CNY 37,919,476.00 in the same period of 2019, indicating a significant improvement[35]. - Cash received from sales of goods and services in the first three quarters of 2020 was CNY 334,159,453.73, down from CNY 450,120,860.29 in the first three quarters of 2019, reflecting a decrease of approximately 25.7%[31]. - The net cash flow from investing activities was negative CNY 96,193,473.41 for the first three quarters of 2020, compared to negative CNY 17,434,646.19 in the same period of 2019, indicating increased investment outflows[32]. - Cash inflows from financing activities totaled CNY 664,119,497.45 in the first three quarters of 2020, down from CNY 1,007,504,283.00 in the same period of 2019, representing a decrease of approximately 34%[32]. - The company reported a net decrease in cash and cash equivalents of CNY 19,807,528.53 for the first three quarters of 2020, contrasting with an increase of CNY 67,467,445.91 in the same period of 2019[32]. - The total cash and cash equivalents at the end of the third quarter of 2020 stood at CNY 851,434,795.68, compared to CNY 697,630,610.09 at the end of the same period in 2019, showing an increase of approximately 22%[32]. Shareholder Information - The total number of shareholders at the end of the reporting period was 77,167[10]. - The largest shareholder, Nantong Zongyi Investment Co., Ltd., held 25.69% of the shares, with 188,000,000 shares pledged[10]. Research and Development - R&D expenses decreased by 40.76% to ¥12,589,205.81 from ¥21,251,921.10, mainly due to changes in the R&D expenses of subsidiary Shenzhen Yinan[13]. - Research and development expenses increased to ¥6,709,073.77 in Q3 2020, compared to ¥3,770,106.75 in Q3 2019, reflecting a 77.5% increase[24]. Investment and Fair Value - Fair value changes in investment income surged by 480.04% to ¥318,454,150.41 from ¥54,902,044.09, driven by significant increases in the fair value of investments in the health and integrated circuit sectors[13]. - The company reported a significant increase in fair value gains, reaching ¥32,666,583.82 in Q3 2020, compared to ¥23,682,112.12 in Q3 2019[24]. Taxation - The company reported a 193.22% increase in income tax expenses to ¥70,662,442.69 from ¥24,098,629.38, primarily due to new provisions related to fair value changes in trading financial assets[13]. - The company reported a significant decrease in total tax expenses, amounting to CNY 6,683,216.70 in Q3 2020, compared to CNY 13,389,487.63 in Q3 2019[25].